GeriCare Senna Syrup

Manufacturer
Geri-Care Pharmaceuticals, Corp
Effective date
2019-06-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:59:38

Label at a glance#

ProductGeriCare Senna Syrup
Active ingredientSENNOSIDES
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Per teaspoonful-5mL

Sennosides - 8.8 mg

OTC - PURPOSE SECTION

Purpose

Laxative

INDICATIONS & USAGE SECTION

Uses

  • relieves occasional constipation (irregularity)
  • generally causes bowel movment in 6 to 12 hours

WARNINGS SECTION

Warnings

Do not use

  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor or pharmacis before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden changed in bowel movement that continues over a period of 2 weeks

Stope use and ask a doctor if

you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.

PREGNANCY SECTION

If pregnant or breast-feeding ask a health professional before use

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately

DOSAGE & ADMINISTRATION SECTION

  • shake well before use
  • Do not exceed recommended dose
 Age Starting Dose Maximum dosage
 Adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor3 teaspoons in the morning and 3 teaspoons at bedtime
Under 12 years of age ask a doctor ask a doctor

INACTIVE INGREDIENT SECTION

Inactive ingredients artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, and sucrose.

OTC - QUESTIONS SECTION

Questions or comments? 1-800-540-3765

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GerriSennaGerriSenna

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
702311sennosides 8.8 MG in 5 mL Oral SolutionPSN1
702311sennosides, USP 1.76 MG/ML Oral SolutionSCD1
702311sennosides 8.8 MG per 5 mL Oral SyrupSY1
702311sennosides, USP 26.4 MG per 15 ML Oral SolutionSY1
702311sennosides, USP 8.8 MG per 5 ML Oral SolutionSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
57896-462-08GeriCare Senna Syrup237 mL in 1 BOTTLELIQUID2371

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
57896-462GERICARE SENNA SYRUP (SENNOSIDES) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]1Legacy NDC, 1 package rows20190610_25035379-f8aa-46ce-8260-1cf579754d8d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
57896-462-08ML - Milliliter57896-46207c47573-a95e-40a7-b81a-07b752b3161012019-07-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57896-46257896-462-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a1c8d43-b8bc-40ac-b05b-f22e21b88b8125035379-f8aa-46ce-8260-1cf579754d8d2019-06-09WarningsExact identifier
spl id: 4a1c8d43-b8bc-40ac-b05b-f22e21b88b81
spl set id: 25035379-f8aa-46ce-8260-1cf579754d8d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.